All

Peer-Reviewed Neuroimaging Data Supports Nexalin’s Technology for Chronic Insomnia

A newly published study reports significant clinical improvement and brain-network modulation in patients treated with the noninvasive neurostimulation device.

All

Nyxoah’s Genio Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

Assignment to New Technology APC 1580 is positive news for Nyxoah’s US commercial rollout.

All

Inspire V Broadly Available in the United States

It streamlines the implant procedure by eliminating the need for a separate sensing lead.

New Trial Reveals Sustained Benefits for Investigational Sleep Apnea Neurostimulator

May 8, 2025 | Emerging Technology

The study features a differentiated neurostimulation modality called proximal hypoglossal nerve stimulation.

Signifier Adds Remote to eXciteOSA to Meet CMS Reimbursement Requirements

Mar 10, 2025 | Reimbursement

Signifier Medical Technologies has launched a new hardware remote control for its eXciteOSA sleep apnea therapy, aligning with CMS requirements to facilitate Medicare and Medicaid reimbursement and expanding patient access to treatment.

Inspire Therapy Alternative Starting Electrode Configuration Improves OSA Less Than 8 Weeks Post-Activation

Mar 3, 2025 | Neurostimulators

A sleep physician shares a case report of how a patient with severe sleep apnea achieved objective and subjective improvements more quickly with Inspire Therapy than via the standard activation and titration protocols.

How to Reduce the Time to Treatment for Patients Getting Sleep Apnea Neurostimulators

Mar 3, 2025 | Neurostimulators

From candidacy to implantation to nightly use, the neurostimulator startup process is inherently lengthy. Sleep specialists can explore ways—from practical to novel—to make the process more efficient.

Nyxoah Named Small Company of the Year at Euronext Brussels Awards

Jan 17, 2025 | Neurostimulators

The maker of the Genio neurostimulator for obstructive sleep apnea received top honors in the gold category as Small Company of the Year, recognizing its excellence in Belgian capital markets.

Inspire Announces Revenue Gains and Organizational Changes

Jan 13, 2025 | Neurostimulators

The company reported a 28% revenue increase for 2024 and unveiled new leadership roles.

Brainwave-Stimulating Sleep Tech to Debut at CES 2025

Dec 26, 2024 | Emerging Technology

Deep Sleep Technologies to debut its non-invasive brainwave-stimulating and modulating sleep technology at CES 2025, designed to improve sleep onset and duration.

Nyxoah’s Genio Neurostimulator for OSA Launches in England

Dec 13, 2024 | Neurostimulators

The launch is marked by the first successful patient implants at University College London Hospitals.

NREM Sleep Boosts Brainpower—And Its Effects Can Be Simulated

Nov 25, 2024 | Brain

Researchers found that NREM sleep enhances brain function and discovered a way to replicate its benefits artificially without requiring sleep.

Investigational Neurostimulator for OSA Cuts AHI By 66%

Nov 13, 2024 | Neurostimulators

Topline clinical trial results demonstrate a 66.2% reduction in apnea-hypopnea index and a 63% reduction in oxygen desaturation after six months of therapy.

Nyxoah Posts Strong Q3 Results, Gears Up for Genio’s Anticipated US Launch

Nov 8, 2024 | Neurostimulators

Nyxoah reports 30% sales growth and secures €24.6 million to support its anticipated US launch of the Genio neurostimulation system.

Inspire Reports 33% Year-over-Year Revenue Growth

Nov 5, 2024 | Neurostimulators

In its Q3 results, Inspire Medical recapped highlights, including expanded therapy centers, FDA approval for its latest device, and publication of long-term safety data.

Using Magnetic Pulses to Combat Insomnia Among Military Personnel

Nov 1, 2024 | Insomnia

A $3 million Department of Defense grant will fund University of Arizona research on using magnetic brain stimulation to address chronic insomnia in military personnel.